These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10210318)

  • 1. Transforming growth factor beta inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795.
    Hu X; Moscinski LC; Zuckerman KS
    Exp Hematol; 1999 Apr; 27(4):605-14. PubMed ID: 10210318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
    Hu X; Zuckerman KS
    Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
    Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ; Simpson DJ; Farrell WE
    Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
    Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
    Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-inhibitory effects of transforming growth factor-beta 1 on myeloid leukemia cell lines.
    Drexler HG; Meyer C; Zaborski M; Uphoff CC; Quentmeier H
    Leuk Res; 1998 Oct; 22(10):927-38. PubMed ID: 9766753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
    Herrera RE; Mäkelä TP; Weinberg RA
    Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
    Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
    Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M; Bergh G; Johnsson E; Gullberg U; Olsson I
    Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase.
    Liu B; Preisig P
    Am J Physiol; 1999 Aug; 277(2):F186-94. PubMed ID: 10444572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.
    Dao MA; Hwa J; Nolta JA
    Blood; 2002 Jan; 99(2):499-506. PubMed ID: 11781230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression.
    Ko TC; Yu W; Sakai T; Sheng H; Shao J; Beauchamp RD; Thompson EA
    Oncogene; 1998 Jul; 16(26):3445-54. PubMed ID: 9692552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T; Yang JL; Price JO; Arteaga CL
    Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.